Related references
Note: Only part of the references are listed.Inhibition of Transforming Growth Factor-β-Mediated Immunosuppression in Tumor-Draining Lymph Nodes Augments Antitumor Responses by Various Immunologic Cell Types
Takuya Fujita et al.
CANCER RESEARCH (2009)
A synthetic peptide from transforming growth factor-β1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats
Nerea Hermida et al.
CARDIOVASCULAR RESEARCH (2009)
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
Christopher P. Denton et al.
ARTHRITIS AND RHEUMATISM (2007)
Inhibition of TGF-beta 2 with AP 12009 in recurrent malignant gliomas: From preclinical to phase I/II studies
Peter Hau et al.
OLIGONUCLEOTIDES (2007)
Spontaneous elicitation of potent antitumor immunity and eradication of established tumors by administration of DNA encoding soluble transforming growth factor-b II receptor without active antigen-sensitization
K Kontani et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Targeted tumor therapy with the TGF-β2 antisense compound AP 12009
KH Schlingensiepen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: Toxicology and safety
R Schlingensiepen et al.
OLIGONUCLEOTIDES (2005)
Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-β type I receptor inhibitors
FO Gellibert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Development of TGF-β signalling inhibitors for cancer therapy
JM Yingling et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain
JS Sawyer et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Effect of aldosterone on renal transforming growth factor-β
I Juknevicius et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Successful shape-based virtual screening:: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)
J Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Synthesis and activity of new aryl- and heteroaryl- substituted pyrazole inhibitors of the transforming growth factor-b type I receptor kinase domain
JS Sawyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury
IJ Ezquerro et al.
CYTOKINE (2003)
Identification of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5)
JF Callahan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
